
| Pair Name | Oridonin, Fluorouracil | ||
| Phytochemical Name | Oridonin (PubChem CID: 5321010 ) | ||
| Anticancer drug Name | Fluorouracil (PubChem CID: 3385 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Oridonin, Fluorouracil | |||
| Disease Info | [ICD-11: 2C90.Z] | Renal carcinoma | Investigative | |
| Biological Phenomena | Induction-->Necroptosis | |||
| Gene Regulation | Up-regulation | Activity | MAPK8 | hsa5599 |
| Up-regulation | Activity | MAPK14 | hsa1432 | |
| Up-regulation | Activity | MAPK1 | hsa5594 | |
| In Vitro Model | 786-O | Renal cell carcinoma | Homo sapiens (Human) | CVCL_1051 |
| In Vivo Model | 786-O cells (1×10⁶) were subcutaneously injected into the right flank. | |||
| Result | Oridonin enhances the cytotoxicity of 5-FU in renal cancer cells partially through inducing necroptosis, providing evidence of using necroptosis inducers in combination with chemotherapeutic agents for cancer treatment. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death. Biomed Pharmacother. 2018 Oct;106:175-182. doi: 10.1016/j.biopha.2018.06.111. | Click |